Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • Faulty Hip Implants:...

    Faulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar Pradesh

    Farhat NasimWritten by Farhat Nasim Published On 2019-08-24T10:56:28+05:30  |  Updated On 24 Aug 2019 10:56 AM IST
    Faulty Hip Implants: JnJ pays Rs 25 lakh each to three victims in Uttar Pradesh

    According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by JnJ.


    Lucknow: Pharma major Johnson & Johnson(JnJ) has paid Rs 25 lakh each to three victims of its faulty acetabular surface replacement (ASR) hip implants in Uttar Pradesh, officials said.


    According to Uttar Pradesh Drug Licensing and Control officer A K Jain, the company has given compensation to three patients who had undergone revision surgeries for the faulty implants made by the company.

    Also Read: JnJ hip implants: CDSCO orders compensation of over Rs 2 crore for 2 more patients

    The Delhi High Court had in May directed JnJ to make an interim payment of Rs 25 lakh each to the 67 patients who have undergone revision surgeries.

    As per a recent media report by PTI, Jain said the Uttar Pradesh Drug Licensing and Control Authority was promptly following such complaints.

    Also Read: JnJ Faulty Hip Implants: 7 more patients found fit for compensation

    Medical Dialogues had earlier reported that JnJ told the Delhi High Court that it was not withholding payment to those patients who underwent revision surgeries for alleged faulty hip implants made by the company and wanted more than the interim compensation of Rs 25 lakh. The submission by JnJ had come in response to a query by Justice Vibhu Bakhru as to what was it doing in cases where patients want more than the Rs 25 lakh.


    Also Read: Not withholding interim compensation from patients who want more: JnJ to HC

    AK Jainarticular surface replacementsArun AgarwalASRDelhi high courtfaulty hip implantfaulty implant compensationfaulty implantsHealth Ministryinterim compensationJnJjnj compensationJnJ faullty implantJnJ implantsjnj victim in UPJohnsonJohnson and JohnsonMaulana Azad Medical CollegeorthopaedicspatientsR K AryaUPUP drug controllerUttar PradeshVibhu Bakhru
    Source : with inputs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok